UroGen Pharma (URGN) News
NASDAQ: URGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
36.83-0.15 (-0.41%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
URGN news summary
We found 2 recent headlines mentioning UroGen Pharma (URGN): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, URGN is down 0.41% at $36.83. The most recent story, "After Hours Most Active for Oct 9, 2026 : FTXR, NVDA, BKD, GRAB, TRVI, URGN, INDV, LUV, WFC, ESI, OSG, BAC", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest UroGen Pharma headlines
- After Hours Most Active for Oct 9, 2026 : FTXR, NVDA, BKD, GRAB, TRVI, URGN, INDV, LUV, WFC, ESI, OSG, BACThe NASDAQ 100 After Hours Indicator is down -5.38 to 30,877.77. The total After hours volume is currently 134,392,844 shares traded.The following are the most active stocks for the after hours…NasdaqFTXR, NVDA, BKD, GRAB
- Here's Why You Should Add URGN Stock to Your Portfolio NowUroGen's Zusduri sales surge, Jelmyto revenues and advancing pipeline assets strengthen its shift toward a commercial growth story.NasdaqURGN, TEVA, ACIU, PGEN